<![CDATA[Actelion Pharmaceuticals Ltd]]> eng http://www.actelion.com Copyright (c)2008 Actelion http://blogs.law.harvard.edu/tech/rss Hugin - http://www.hugingroup.com/ webmaster@actelion.com webmaster@actelion.com 10 <![CDATA[Actelion Pharmaceuticals Ltd]]> http://www.huginonline.ch/ATLN/logo.gif http://www.actelion.com 195 98 <![CDATA[Actelion receives FDA complete response letter for Zavesca (miglustat) for the treatment of Niemann-Pick type C disease]]> Tue, 9 Mar 2010 17:45:00 +0100 http://cws.huginonline.com/A/131801/PR/201003/1392243_5.html Actelion Pharmaceuticals Ltd <![CDATA[BUILD-3 study with bosentan in idiopathic pulmonary fibrosis does not meet primary endpoint]]> Mon, 1 Mar 2010 07:00:00 +0100 http://cws.huginonline.com/A/131801/PR/201003/1389329_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion publishes Annual Report 2009]]> Thu, 18 Feb 2010 08:46:37 +0100 http://cws.huginonline.com/A/131801/PR/201002/1385862_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion announces Full year 2009 financial results]]> Thu, 18 Feb 2010 07:00:00 +0100 http://cws.huginonline.com/A/131801/PR/201002/1385660_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion to Present at the 12th Annual BIO CEO & Investor Conference]]> Fri, 5 Feb 2010 17:35:00 +0100 http://cws.huginonline.com/A/131801/PR/201002/1381302_5.html Actelion Pharmaceuticals Ltd <![CDATA[Zavesca® (miglustat) receives positive vote from the FDA's Endocrinologic and Metabolic Drugs Advisory Committee for the treatment of Niemann-Pick type C disease]]> Tue, 12 Jan 2010 22:32:04 +0100 http://cws.huginonline.com/A/131801/PR/201001/1372896_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion to Present at the 28th Annual J.P. Morgan Healthcare Conference]]> Mon, 11 Jan 2010 17:35:00 +0100 http://cws.huginonline.com/A/131801/PR/201001/1372270_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion reports arbitration results between subsidiary CoTherix, Inc. and Asahi Kasei Pharma Corporation]]> Tue, 22 Dec 2009 07:00:00 +0100 http://cws.huginonline.com/A/131801/PR/200912/1366100_5.html Actelion Pharmaceuticals Ltd <![CDATA[Investigational dual orexin receptor antagonist almorexant meets primary endpoint in two-week phase III study in patients suffering from primary insomnia ]]> Mon, 21 Dec 2009 07:00:00 +0100 http://cws.huginonline.com/A/131801/PR/200912/1365361_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion's selective S1P1 receptor agonist moves into advanced clinical development in psoriasis - Phase IIb dose-finding study in multiple sclerosis already ongoing - Roche to leave S1P1 alliance following comprehensive portfolio review and prioritization]]> Tue, 8 Dec 2009 07:00:00 +0100 http://cws.huginonline.com/A/131801/PR/200912/1359631_5.html Actelion Pharmaceuticals Ltd <![CDATA[US Food and Drug Administration grants priority review for Actelion's miglustat in Niemann-Pick type C disease ]]> Thu, 19 Nov 2009 07:00:00 +0100 http://cws.huginonline.com/A/131801/PR/200911/1356015_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion announces 9-month financial results 2009]]> Tue, 20 Oct 2009 07:00:00 +0200 http://cws.huginonline.com/A/131801/PR/200910/1348272_5.html Actelion Pharmaceuticals Ltd <![CDATA[Dose-finding Phase IIb study started in patients with multiple sclerosis - Actelion/Roche S1P1 alliance achieves clinical milestone ]]> Fri, 9 Oct 2009 07:00:00 +0200 http://cws.huginonline.com/A/131801/PR/200910/1346473_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion updates US Healthcare Professionals for patients with type 1 Gaucher disease - Information on the potential use of Zavesca® (miglustat) oral capsule to address the supply shortage of intravenous enzyme replacement therapy (imiglucerase) ]]> Tue, 8 Sep 2009 17:35:00 +0200 http://cws.huginonline.com/A/131801/PR/200909/1339270_5.html Actelion Pharmaceuticals Ltd <![CDATA[Tracleer receives label extension in the US for the treatment of patients with mildly symptomatic WHO Functional Class II pulmonary arterial hypertension]]> Mon, 10 Aug 2009 07:05:00 +0200 http://cws.huginonline.com/A/131801/PR/200908/1333588_5.html Actelion Pharmaceuticals Ltd <![CDATA[Ventavis (Iloprost) in pulmonary arterial hypertension receives US approval for increased 20 mcg/ml strength formulation ]]> Mon, 10 Aug 2009 06:55:00 +0200 http://cws.huginonline.com/A/131801/PR/200908/1330336_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion announces Half Year financial results 2009]]> Tue, 21 Jul 2009 07:00:00 +0200 http://cws.huginonline.com/A/131801/PR/200907/1329884_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion's PGI2 receptor agonist demonstrates efficacy in pulmonary arterial hypertension patients - Morbidity-Mortality Phase III study to be initiated before year-end]]> Fri, 17 Jul 2009 07:00:00 +0200 http://cws.huginonline.com/A/131801/PR/200907/1329274_5.html Actelion Pharmaceuticals Ltd <![CDATA[Tracleer (bosentan) receives EU approval for pediatric formulation - the first and only licensed pulmonary arterial hypertension therapy for children ]]> Mon, 6 Jul 2009 07:00:00 +0200 http://cws.huginonline.com/A/131801/PR/200907/1327164_5.html Actelion Pharmaceuticals Ltd <![CDATA[Management change at Actelion - Isaac Kobrin to take newly created position of Chief Medical Officer - Guy Braunstein to join as new Head of Clinical Development]]> Fri, 12 Jun 2009 07:00:00 +0200 http://cws.huginonline.com/A/131801/PR/200906/1321948_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion provides update on BUILD-3 study in Idiopathic Pulmonary Fibrosis - Study continues as recommended by the Independent Data and Safety Monitoring Board]]> Fri, 8 May 2009 07:00:00 +0200 http://cws.huginonline.com/A/131801/PR/200905/1312492_5.html Actelion Pharmaceuticals Ltd <![CDATA[Bosentan (Tracleer®) receives positive CHMP opinion for pediatric formulation ]]> Fri, 24 Apr 2009 17:35:00 +0200 http://cws.huginonline.com/A/131801/PR/200904/1307764_5.html Actelion Pharmaceuticals Ltd <![CDATA[Annual General Meeting of Shareholders in Basel, Switzerland]]> Fri, 24 Apr 2009 13:00:00 +0200 http://cws.huginonline.com/A/131801/PR/200904/1307790_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion announces first quarter 2009 financial results]]> Tue, 21 Apr 2009 07:00:00 +0200 http://cws.huginonline.com/A/131801/PR/200904/1306496_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion proposes expansion of its Board of Directors]]> Fri, 27 Mar 2009 17:35:00 +0100 http://cws.huginonline.com/A/131801/PR/200903/1301120_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion Co-Founder Walter Fischli to focus on advancing scientific relationships between Actelion and leading academic institutes - Beat Steiner new Co-Head of Drug Discovery]]> Thu, 12 Mar 2009 17:35:00 +0100 http://cws.huginonline.com/A/131801/PR/200903/1297379_5.html Actelion Pharmaceuticals Ltd <![CDATA[US Food and Drug Administration issues complete response letter regarding the Tracleer® supplemental New Drug Application - Completion and Approval of Risk Evaluation and Mitigation System (REMS) submission required for final FDA review for inclusion of less severe PAH patients in the product label ]]> Mon, 2 Mar 2009 07:00:00 +0100 http://cws.huginonline.com/A/131801/PR/200903/1294162_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion announces acquisition of a new formulation of intravenous epoprostenol with improved thermal stability for the treatment of Pulmonary Arterial Hypertension]]> Mon, 23 Feb 2009 07:00:00 +0100 http://cws.huginonline.com/A/131801/PR/200902/1292312_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion announces Full Year 2008 financial results]]> Thu, 19 Feb 2009 07:00:00 +0100 http://cws.huginonline.com/A/131801/PR/200902/1291716_5.html Actelion Pharmaceuticals Ltd <![CDATA[Zavesca® (miglustat) receives EU approval for the treatment of progressive neurological manifestations in patients with Niemann-Pick type C disease ]]> Thu, 29 Jan 2009 17:35:00 +0100 http://cws.huginonline.com/A/131801/PR/200901/1285831_5.html Actelion Pharmaceuticals Ltd <![CDATA[Miglustat (Zavesca®) receives positive opinion from the European Committee for Medicinal Products for Human Use for an extension of indication for Niemann-Pick type C disease]]> Fri, 19 Dec 2008 07:00:00 +0100 http://cws.huginonline.com/A/131801/PR/200812/1278356_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion's first-in-class selective S1P1 receptor agonist to enter Phase II clinical development]]> Thu, 13 Nov 2008 07:00:00 +0100 http://cws.huginonline.com/A/131801/PR/200811/1269131_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion announces 9-months results for 2008]]> Tue, 21 Oct 2008 07:00:00 +0200 http://cws.huginonline.com/A/131801/PR/200810/1261085_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion included in the Swiss Market Index SMI]]> Mon, 22 Sep 2008 07:00:00 +0200 http://cws.huginonline.com/A/131801/PR/200809/1253080_5.html Actelion Pharmaceuticals Ltd <![CDATA[Tracleer® (bosentan) receives EU approval for treatment of patients with mildly symptomatic Pulmonary Arterial Hypertension]]> Mon, 4 Aug 2008 07:00:00 +0200 http://cws.huginonline.com/A/131801/PR/200808/1240088_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion announces Half Year financial results 2008]]> Tue, 22 Jul 2008 07:00:00 +0200 http://cws.huginonline.com/A/131801/PR/200807/1237443_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion and GlaxoSmithKline enter into exclusive collaboration to realise the full potential of almorexant in sleep disorders and beyond]]> Mon, 14 Jul 2008 07:00:00 +0200 http://cws.huginonline.com/A/131801/PR/200807/1235543_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion to join the SMI (Swiss Market Index) ]]> Tue, 8 Jul 2008 18:15:00 +0200 http://cws.huginonline.com/A/131801/PR/200807/1234505_5.html Actelion Pharmaceuticals Ltd <![CDATA[Bosentan (Tracleer®) receives positive EU opinion for treatment of patients with mildly symptomatic WHO Functional Class II pulmonary arterial hypertension ]]> Fri, 27 Jun 2008 07:00:00 +0200 http://cws.huginonline.com/A/131801/PR/200806/1231527_5.html Actelion Pharmaceuticals Ltd <![CDATA[Pivotal pulmonary arterial hypertension study published in The Lancet concludes that bosentan (Tracleer®) demonstrates benefits in patients with mildly symptomatic WHO Functional Class II disease]]> Fri, 20 Jun 2008 01:02:00 +0200 http://cws.huginonline.com/A/131801/PR/200806/1229556_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion announces first quarter 2008 financial results]]> Tue, 22 Apr 2008 07:00:00 +0200 http://cws.huginonline.com/A/131801/PR/200804/1211488_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion and Nippon Shinyaku enter into a license agreement on novel PAH compound ]]> Mon, 21 Apr 2008 08:01:00 +0200 http://cws.huginonline.com/A/131801/PR/200804/1210833_5.html Actelion Pharmaceuticals Ltd <![CDATA[Annual General Meeting of Shareholders in Basel, Switzerland]]> Fri, 11 Apr 2008 12:30:00 +0200 http://cws.huginonline.com/A/131801/PR/200804/1208262_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion and Nippon Shinyaku to collaborate on novel PAH compound]]> Fri, 29 Feb 2008 10:33:00 +0100 http://cws.huginonline.com/A/131801/PR/200802/1201545_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion announces Full Year 2007 financial results]]> Thu, 21 Feb 2008 10:21:00 +0100 http://cws.huginonline.com/A/131801/PR/200802/1201523_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion reports total net revenues for 2007]]> Mon, 21 Jan 2008 07:00:00 +0100 http://cws.huginonline.com/A/131801/PR/200801/1185199_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion enters Phase III with novel orexin receptor antagonist almorexant - RESTORA program to confirm efficacy and safety in patients suffering from primary insomnia - RESTORA 1 with active reference arm initiated ]]> Thu, 20 Dec 2007 07:00:00 +0100 http://cws.huginonline.com/A/131801/PR/200712/1185234_5.html Actelion Pharmaceuticals Ltd <![CDATA[Phase III study initiated with Actelion-1 - Highly potent tissue-targeting endothelin receptor antagonist - Largest study ever in PAH to demonstrate morbidity/mortality benefits]]> Wed, 19 Dec 2007 07:00:00 +0100 http://cws.huginonline.com/A/131801/PR/200712/1185758_5.html Actelion Pharmaceuticals Ltd <![CDATA[10 Year Anniversary of Actelion - Now full member of Interpharma, the Swiss Association of Pharmaceutical Research Companies]]> Tue, 18 Dec 2007 07:00:00 +0100 http://cws.huginonline.com/A/131801/PR/200712/1186037_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion provides update on bosentan in metastatic melanoma]]> Mon, 17 Dec 2007 07:00:00 +0100 http://cws.huginonline.com/A/131801/PR/200712/1186044_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion/Merck & Co., Inc. Renin alliance achieves fourth milestone - Dosing in Phase II initiated - Actelion receives USD 10 million]]> Wed, 5 Dec 2007 15:17:00 +0100 http://cws.huginonline.com/A/131801/PR/200712/1202135_5.html Actelion Pharmaceuticals Ltd <![CDATA[Management change at Actelion - Otto Schwarz to join as new Head of Business Operations]]> Thu, 29 Nov 2007 15:11:00 +0100 http://cws.huginonline.com/A/131801/PR/200711/1202130_5.html Actelion Pharmaceuticals Ltd <![CDATA[Pivlaz® (clazosentan) Phase III study initiated to demonstrate prevention of vasospasm-related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage]]> Mon, 12 Nov 2007 14:26:00 +0100 http://cws.huginonline.com/A/131801/PR/200711/1202095_5.html Actelion Pharmaceuticals Ltd <![CDATA[Miglustat (Zavesca®) receives negative opinion from the European Committee for Medicinal Products for Human Use for extension of indication for Niemann Pick type C]]> Fri, 19 Oct 2007 14:21:00 +0200 http://cws.huginonline.com/A/131801/PR/200710/1202091_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion announces 9-months results for 2007]]> Thu, 18 Oct 2007 07:00:00 +0200 http://cws.huginonline.com/A/131801/PR/200710/1170544_5.html Actelion Pharmaceuticals Ltd <![CDATA[Miglustat enters Phase IIa for Cystic Fibrosis]]> Fri, 28 Sep 2007 14:16:00 +0200 http://cws.huginonline.com/A/131801/PR/200709/1202081_5.html Actelion Pharmaceuticals Ltd <![CDATA[EARLY: First PAH functional class II population study emphasizes need to diagnose and treat PAH early]]> Mon, 3 Sep 2007 11:22:00 +0200 http://cws.huginonline.com/A/131801/PR/200709/1201989_5.html Actelion Pharmaceuticals Ltd <![CDATA[New data on orexin receptor antagonist almorexant shows therapeutic potential to restore normal physiological sleep in patients suffering from insomnia]]> Sun, 2 Sep 2007 11:25:00 +0200 http://cws.huginonline.com/A/131801/PR/200709/1201991_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion announces Half Year financial results 2007]]> Thu, 19 Jul 2007 11:19:00 +0200 http://cws.huginonline.com/A/131801/PR/200707/1201985_5.html Actelion Pharmaceuticals Ltd <![CDATA[Bosentan (Tracleer®) receives EU approval for reduction of number of new digital ulcerations in systemic sclerosis patients]]> Mon, 11 Jun 2007 11:15:00 +0200 http://cws.huginonline.com/A/131801/PR/200706/1201983_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion Stock Split 1:5 effective Wednesday, ]]> Thu, 31 May 2007 11:07:00 +0200 http://cws.huginonline.com/A/131801/PR/200705/1201969_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion announces first quarter results 2007]]> Thu, 19 Apr 2007 11:04:00 +0200 http://cws.huginonline.com/A/131801/PR/200704/1201966_5.html Actelion Pharmaceuticals Ltd <![CDATA[Bosentan (Tracleer®) receives positive EU opinion for reduction of new digital ulcerations in systemic sclerosis patients]]> Mon, 26 Mar 2007 10:24:00 +0200 http://cws.huginonline.com/A/131801/PR/200703/1201939_5.html Actelion Pharmaceuticals Ltd <![CDATA[Positive study with bosentan (Tracleer®) in CTEPH]]> Mon, 5 Mar 2007 10:22:00 +0100 http://cws.huginonline.com/A/131801/PR/200703/1201937_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion announces Full Year 2006 financial results]]> Thu, 22 Feb 2007 14:55:00 +0100 http://cws.huginonline.com/A/131801/PR/200702/1209495_5.html Actelion Pharmaceuticals Ltd <![CDATA[Successful Proof-of-Concept with Actelion's Orexin Receptor Antagonist in patients suffering from primary insomnia - First demonstration of key role of Orexin System in humans suffering from sleep disorders]]> Mon, 5 Feb 2007 13:17:00 +0100 http://cws.huginonline.com/A/131801/PR/200702/1201932_5.html Actelion Pharmaceuticals Ltd <![CDATA[Publication in Nature Medicine highlights potential of Actelion's Orexin Receptor Antagonist as a novel mechanism to treat sleep disorders]]> Mon, 29 Jan 2007 10:03:00 +0100 http://cws.huginonline.com/A/131801/PR/200701/1201925_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion calls its Zero Coupon Convertible Bond 2003-2008]]> Thu, 18 Jan 2007 09:59:00 +0100 http://cws.huginonline.com/A/131801/PR/200701/1201923_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion Ltd. Announces Successful Completion of its Cash Tender Offer for Shares of CoTherix, Inc.]]> Tue, 9 Jan 2007 09:56:00 +0100 http://cws.huginonline.com/A/131801/PR/200701/1201919_5.html Actelion Pharmaceuticals Ltd <![CDATA[Successful study with Tracleer® in patients with mildly symptomatic Pulmonary Arterial Hypertension ]]> Mon, 18 Dec 2006 16:13:00 +0100 http://cws.huginonline.com/A/131801/PR/200612/1204004_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion-1 - first tissue-targeting endothelin receptor antagonist - in Phase III for Pulmonary Hypertension (PH)]]> Mon, 11 Dec 2006 16:09:00 +0100 http://cws.huginonline.com/A/131801/PR/200612/1203999_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion Finance SCA Issues Convertible Bond]]> Thu, 9 Nov 2006 14:38:00 +0100 http://cws.huginonline.com/A/131801/PR/200611/1209481_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion announces 9-month results for 2006]]> Thu, 19 Oct 2006 14:32:00 +0200 http://cws.huginonline.com/A/131801/PR/200610/1209478_5.html Actelion Pharmaceuticals Ltd <![CDATA[Detailed analysis of CONSCIOUS-1 presented at CNS]]> Mon, 9 Oct 2006 14:24:00 +0200 http://cws.huginonline.com/A/131801/PR/200610/1209471_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion announces Half Year financial results 2006]]> Thu, 20 Jul 2006 14:22:00 +0200 http://cws.huginonline.com/A/131801/PR/200607/1209468_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion and Roche enter into autoimmune disorder collaboration ]]> Mon, 17 Jul 2006 14:17:00 +0200 http://cws.huginonline.com/A/131801/PR/200607/1209466_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion/Merck Renin alliance achieves third milestone]]> Thu, 6 Jul 2006 14:05:00 +0200 http://cws.huginonline.com/A/131801/PR/200607/1209459_5.html Actelion Pharmaceuticals Ltd <![CDATA[Preliminary results of CONSCIOUS-1 - Significant reduction of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage - Primary endpoint achieved - No overall effect seen in secondary clinical outcome endpoints - Further data analysis needed to determine future development path]]> Mon, 19 Jun 2006 14:00:00 +0200 http://cws.huginonline.com/A/131801/PR/200606/1209456_5.html Actelion Pharmaceuticals Ltd <![CDATA[ATS presentation highlights strong rationale for a morbidity/mortality study with bosentan in Idiopathic Pulmonary Fibrosis (IPF)]]> Tue, 23 May 2006 16:37:00 +0200 http://cws.huginonline.com/A/131801/PR/200605/1204015_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion announces first quarter results 2006]]> Thu, 20 Apr 2006 16:34:00 +0200 http://cws.huginonline.com/A/131801/PR/200604/1204013_5.html Actelion Pharmaceuticals Ltd <![CDATA[Annual General Meeting of Shareholders in Basel, Switzerland]]> Mon, 10 Apr 2006 14:47:00 +0200 http://cws.huginonline.com/A/131801/PR/200604/1209487_5.html Actelion Pharmaceuticals Ltd <![CDATA[Bosentan studies in pulmonary fibrosis show no effect on primary exercise improvement endpoint - Secondary endpoints related to death or disease worsening provide strong rationale for Phase III mortality/morbidity study in Idiopathic Pulmonary Fibrosis (IPF)]]> Mon, 28 Nov 2005 10:03:00 +0100 http://cws.huginonline.com/A/131801/PR/200511/1209775_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion and UCB enter into assignment and license agreement for Zavesca® (miglustat)]]> Thu, 17 Nov 2005 09:56:00 +0100 http://cws.huginonline.com/A/131801/PR/200511/1209765_5.html Actelion Pharmaceuticals Ltd <![CDATA[ACR poster presentation highlights clinical data about bosentan in systemic sclerosis patients suffering from digital ulceration]]> Wed, 16 Nov 2005 09:48:00 +0100 http://cws.huginonline.com/A/131801/PR/200511/1209746_5.html Actelion Pharmaceuticals Ltd <![CDATA[One-Year results on the use of miglustat (Zavesca®) in Niemann Pick Type C presented at the annual conference of the American Society of Human Genetics]]> Thu, 27 Oct 2005 09:27:00 +0200 http://cws.huginonline.com/A/131801/PR/200510/1209743_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion announces 9-month results for 2005]]> Wed, 19 Oct 2005 09:23:00 +0200 http://cws.huginonline.com/A/131801/PR/200510/1209739_5.html Actelion Pharmaceuticals Ltd <![CDATA[Tracleer Excellence Post Marketing Surveillance Programme (TRAX PMSTM) confirms long-term safety profile in various pulmonary arterial hypertension subgroups]]> Mon, 5 Sep 2005 16:38:00 +0200 http://cws.huginonline.com/A/131801/PR/200509/1209591_5.html Actelion Pharmaceuticals Ltd <![CDATA[JACC publication on Tracleer® in children with PAH]]> Tue, 16 Aug 2005 16:36:00 +0200 http://cws.huginonline.com/A/131801/PR/200508/1209586_5.html Actelion Pharmaceuticals Ltd <![CDATA[Second study with bosentan (Tracleer®) demonstrating a statistically significant reduction of new digital ulcers in patients with systemic sclerosis]]> Tue, 9 Aug 2005 16:34:00 +0200 http://cws.huginonline.com/A/131801/PR/200508/1209580_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion announces Half Year financial results 2005]]> Thu, 28 Jul 2005 16:28:00 +0200 http://cws.huginonline.com/A/131801/PR/200507/1209576_5.html Actelion Pharmaceuticals Ltd <![CDATA[Tracleer® study first ever to show benefits in Eisenmenger's syndrome]]> Tue, 12 Jul 2005 16:26:00 +0200 http://cws.huginonline.com/A/131801/PR/200507/1209574_5.html Actelion Pharmaceuticals Ltd <![CDATA[Newly published study suggests role for clazosentan in the prevention of cerebral vasospasm after aneurysmal subarachnoid haemorrhage]]> Mon, 4 Jul 2005 16:24:00 +0200 http://cws.huginonline.com/A/131801/PR/200507/1209572_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion launches Tracleer® in PAH in Japan]]> Wed, 8 Jun 2005 16:19:00 +0200 http://cws.huginonline.com/A/131801/PR/200506/1209562_5.html Actelion Pharmaceuticals Ltd <![CDATA[Long-term Tracleer (bosentan) safety profile confirmed with completion of non-interventional program in almost 5,000 patients]]> Tue, 24 May 2005 16:13:00 +0200 http://cws.huginonline.com/A/131801/PR/200505/1209560_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion provides update on palosuran in diabetic nephropathy]]> Mon, 23 May 2005 16:11:00 +0200 http://cws.huginonline.com/A/131801/PR/200505/1209557_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion announces first quarter results 2005]]> Thu, 21 Apr 2005 16:09:00 +0200 http://cws.huginonline.com/A/131801/PR/200504/1209555_5.html Actelion Pharmaceuticals Ltd <![CDATA[Annual General Meeting of the Shareholders in Basel, Switzerland]]> Thu, 14 Apr 2005 16:05:00 +0200 http://cws.huginonline.com/A/131801/PR/200504/1209550_5.html Actelion Pharmaceuticals Ltd <![CDATA[Japanese Approval for Tracleer in PAH]]> Mon, 11 Apr 2005 16:01:00 +0200 http://cws.huginonline.com/A/131801/PR/200504/1209544_5.html Actelion Pharmaceuticals Ltd <![CDATA[Renin alliance of Actelion and Merck & Co., Inc. achieves second milestone]]> Tue, 15 Mar 2005 15:55:00 +0100 http://cws.huginonline.com/A/131801/PR/200503/1209535_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion provides update on bosentan in Japan]]> Mon, 28 Feb 2005 15:49:00 +0100 http://cws.huginonline.com/A/131801/PR/200502/1209526_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion announces Full Year 2004 financial results]]> Thu, 24 Feb 2005 15:52:00 +0100 http://cws.huginonline.com/A/131801/PR/200502/1209533_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion provides update on bosentan in Japan]]> Fri, 18 Feb 2005 15:43:00 +0100 http://cws.huginonline.com/A/131801/PR/200502/1209520_5.html Actelion Pharmaceuticals Ltd <![CDATA[Scientific Publication on long-term bosentan use in PPH]]> Tue, 1 Feb 2005 15:40:00 +0100 http://cws.huginonline.com/A/131801/PR/200502/1209518_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion initiates Phase IIb/III program with clazosentan]]> Wed, 22 Dec 2004 15:09:00 +0100 http://cws.huginonline.com/A/131801/PR/200412/1209995_5.html Actelion Pharmaceuticals Ltd <![CDATA[Zavesca trial continues in Late Onset Tay-Sachs disease]]> Tue, 21 Dec 2004 15:05:00 +0100 http://cws.huginonline.com/A/131801/PR/200412/1209992_5.html Actelion Pharmaceuticals Ltd <![CDATA[Scientific Publication of RAPIDS-1 study with bosentan]]> Mon, 20 Dec 2004 15:03:00 +0100 http://cws.huginonline.com/A/131801/PR/200412/1209989_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion provides update on bosentan in Japan]]> Tue, 9 Nov 2004 15:01:00 +0100 http://cws.huginonline.com/A/131801/PR/200411/1209986_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion stops acute heart failure study]]> Sun, 7 Nov 2004 14:58:00 +0100 http://cws.huginonline.com/A/131801/PR/200411/1209983_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion announces 9-month results for 2004]]> Tue, 26 Oct 2004 14:54:00 +0200 http://cws.huginonline.com/A/131801/PR/200410/1209981_5.html Actelion Pharmaceuticals Ltd <![CDATA[New scientific studies show higher than expected prevalence of Pulmonary Arterial Hypertension in patients with Connective Tissue Diseases (CTD)]]> Mon, 18 Oct 2004 14:47:00 +0200 http://cws.huginonline.com/A/131801/PR/200410/1209975_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion announces half-year results 2004]]> Tue, 27 Jul 2004 14:39:00 +0200 http://cws.huginonline.com/A/131801/PR/200407/1209971_5.html Actelion Pharmaceuticals Ltd <![CDATA[Extended license agreement for Zavesca]]> Wed, 16 Jun 2004 14:35:00 +0200 http://cws.huginonline.com/A/131801/PR/200406/1209967_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion announces first quarter results 2004]]> Tue, 27 Apr 2004 11:20:00 +0200 http://cws.huginonline.com/A/131801/PR/200404/1209827_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion / Merck Renin alliance achieves first milestone]]> Tue, 2 Mar 2004 12:01:00 +0100 http://cws.huginonline.com/A/131801/PR/200403/1209865_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion announces Full Year 2003 financial results]]> Tue, 2 Mar 2004 11:14:00 +0100 http://cws.huginonline.com/A/131801/PR/200403/1209822_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion honored with James D. Watson Helix 2004 Award ]]> Wed, 25 Feb 2004 11:07:00 +0100 http://cws.huginonline.com/A/131801/PR/200402/1209820_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion adopts US GAAP accounting standard for its financial reporting ]]> Thu, 12 Feb 2004 11:04:00 +0100 http://cws.huginonline.com/A/131801/PR/200402/1209817_5.html Actelion Pharmaceuticals Ltd <![CDATA[Cerep to acquire Clinical Development Service Organization Hesperion]]> Thu, 15 Jan 2004 10:58:00 +0100 http://cws.huginonline.com/A/131801/PR/200401/1209808_5.html Actelion Pharmaceuticals Ltd <![CDATA[Zavesca® Capsules Available for Prescription in the US]]> Mon, 5 Jan 2004 08:37:00 +0100 http://cws.huginonline.com/A/131801/PR/200401/1240670_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion reports further progress to additional markets for Tracleer® in Pulmonary Arterial Hypertension]]> Mon, 15 Dec 2003 16:09:00 +0100 http://cws.huginonline.com/A/131801/PR/200312/1210017_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion and Merck form renin inhibitor alliance]]> Thu, 4 Dec 2003 16:24:00 +0100 http://cws.huginonline.com/A/131801/PR/200312/1210032_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion announces 9-month results for 2003 ]]> Tue, 28 Oct 2003 16:28:00 +0100 http://cws.huginonline.com/A/131801/PR/200310/1210039_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion acquires privately held Axovan AG:]]> Tue, 30 Sep 2003 16:31:00 +0200 http://cws.huginonline.com/A/131801/PR/200309/1210042_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion Ltd and Axovan AG enter research collaboration]]> Tue, 17 Jun 2003 16:54:00 +0200 http://cws.huginonline.com/A/131801/PR/200306/1210061_5.html Actelion Pharmaceuticals Ltd <![CDATA[New analysis suggests treatment with Tracleer (bosentan) is associated with improved survival in primary pulmonary hypertension patients]]> Tue, 20 May 2003 17:03:00 +0200 http://cws.huginonline.com/A/131801/PR/200305/1210070_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion announces first quarter results 2003; sustainable profitability ahead of schedule]]> Tue, 29 Apr 2003 17:07:00 +0200 http://cws.huginonline.com/A/131801/PR/200304/1210075_5.html Actelion Pharmaceuticals Ltd <![CDATA[American Thoracic Society publishes abstract on positive long-term survival data with Tracleer® (bosentan) in patients with primary pulmonary hypertension]]> Wed, 23 Apr 2003 17:15:00 +0200 http://cws.huginonline.com/A/131801/PR/200304/1210089_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion files New Drug Application for Tracleer® in Japan ]]> Tue, 8 Apr 2003 17:18:00 +0200 http://cws.huginonline.com/A/131801/PR/200304/1210092_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion starts launch of Zavesca® in the European Union - Patients in UK first to benefit from first oral treatment for type 1 Gaucher's disease - Re-Filing in the United States in progress ]]> Mon, 3 Mar 2003 17:21:00 +0100 http://cws.huginonline.com/A/131801/PR/200303/1210097_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion announces fourth quarter and full year 2002 financial results above expectations]]> Tue, 18 Feb 2003 15:29:00 +0100 http://cws.huginonline.com/A/131801/PR/200302/1224800_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion 2002 operating revenues at CHF 140,3 million]]> Thu, 23 Jan 2003 15:24:00 +0100 http://cws.huginonline.com/A/131801/PR/200301/1224797_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion nominates new Chief Financial Officer]]> Mon, 16 Dec 2002 15:21:00 +0100 http://cws.huginonline.com/A/131801/PR/200212/1224791_5.html Actelion Pharmaceuticals Ltd <![CDATA[Worldwide licence agreement signed by OGS and Actelion]]> Tue, 26 Nov 2002 13:54:00 +0100 http://cws.huginonline.com/A/131801/PR/200211/1224761_5.html Actelion Pharmaceuticals Ltd <![CDATA[European Commission approval for Zavesca(TM) ]]> Tue, 26 Nov 2002 13:51:00 +0100 http://cws.huginonline.com/A/131801/PR/200211/1224759_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion reports 3rd quarter results 2002]]> Tue, 5 Nov 2002 13:48:00 +0100 http://cws.huginonline.com/A/131801/PR/200211/1224754_5.html Actelion Pharmaceuticals Ltd <![CDATA[Successful prevention study with Tracleer in scleroderma-related Digital Ulcerations presented at the American College of Rheumatology]]> Tue, 29 Oct 2002 13:46:00 +0100 http://cws.huginonline.com/A/131801/PR/200210/1224751_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion to initiate registration study with VeletriTM in Acute Heart Failure - Successful dose-optimization study]]> Thu, 12 Sep 2002 13:43:00 +0200 http://cws.huginonline.com/A/131801/PR/200209/1224748_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion to list on SWX Main Market on 9 September 2002]]> Tue, 27 Aug 2002 13:40:00 +0200 http://cws.huginonline.com/A/131801/PR/200208/1224745_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion reports highly significant study results with TracleerTM in Digital Ulcers ]]> Thu, 15 Aug 2002 13:38:00 +0200 http://cws.huginonline.com/A/131801/PR/200208/1224741_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion's New Electronic Stay Informed Service]]> Thu, 15 Aug 2002 13:35:00 +0200 http://cws.huginonline.com/A/131801/PR/200208/1224737_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion reports new safety data on TracleerTM in PAH]]> Wed, 7 Aug 2002 13:33:00 +0200 http://cws.huginonline.com/A/131801/PR/200208/1224735_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion reports 2nd quarter results 2002]]> Wed, 7 Aug 2002 13:28:00 +0200 http://cws.huginonline.com/A/131801/PR/200208/1224733_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion joins Interpharma as associate member ]]> Tue, 30 Jul 2002 13:25:00 +0200 http://cws.huginonline.com/A/131801/PR/200207/1224727_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion and OGS announce marketing and distribution partnership for ZavescaTM in Europe ]]> Fri, 26 Jul 2002 13:23:00 +0200 http://cws.huginonline.com/A/131801/PR/200207/1224724_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion intends to list on the SWX Main Market]]> Wed, 24 Jul 2002 13:20:00 +0200 http://cws.huginonline.com/A/131801/PR/200207/1224720_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion starts introduction of Tracleer(TM) in the EU]]> Thu, 6 Jun 2002 13:17:00 +0200 http://cws.huginonline.com/A/131801/PR/200206/1224718_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion reports positive data from Breathe-3 clinical study]]> Wed, 5 Jun 2002 13:12:00 +0200 http://cws.huginonline.com/A/131801/PR/200206/1224710_5.html Actelion Pharmaceuticals Ltd <![CDATA[EU Commission grants marketing approval for Tracleer(TM)]]> Mon, 20 May 2002 13:06:00 +0200 http://cws.huginonline.com/A/131801/PR/200205/1224706_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion reports 1st quarter results 2002]]> Tue, 7 May 2002 13:04:00 +0200 http://cws.huginonline.com/A/131801/PR/200205/1224703_5.html Actelion Pharmaceuticals Ltd <![CDATA[The New England Journal of Medicine publishes landmark study highlighting efficacy of Tracleer in life-threatening lung condition]]> Wed, 20 Mar 2002 12:59:00 +0100 http://cws.huginonline.com/A/131801/PR/200203/1224701_5.html Actelion Pharmaceuticals Ltd <![CDATA[Berna Biotech and Hesperion create clinical development partnership for new vaccines]]> Wed, 13 Mar 2002 12:57:00 +0100 http://cws.huginonline.com/A/131801/PR/200203/1224699_5.html Actelion Pharmaceuticals Ltd <![CDATA[Swissmedic approves Actelions' Tracleer®]]> Mon, 11 Mar 2002 12:52:00 +0100 http://cws.huginonline.com/A/131801/PR/200203/1224697_5.html Actelion Pharmaceuticals Ltd <![CDATA[Tracleer(TM) in PAH receives favorable Opinion from European Union authorities]]> Fri, 22 Feb 2002 12:50:00 +0100 http://cws.huginonline.com/A/131801/PR/200202/1224694_5.html Actelion Pharmaceuticals Ltd <![CDATA[Phase III Tracleer(TM) (bosentan) Study in Chronic Heart Failure Does Not Meet Primary Efficacy Objective]]> Thu, 7 Feb 2002 12:48:00 +0100 http://cws.huginonline.com/A/131801/PR/200202/1224692_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion grants commercial license to Neopharm Ltd to sell Tracleer(TM) in Israel]]> Mon, 10 Dec 2001 15:46:00 +0100 http://cws.huginonline.com/A/131801/PR/200112/1212077_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion Announces U.S. Commercial Availability of Tracleer(TM) (bosentan) tablets - First Oral Treatment for Pulmonary Arterial Hypertension Ready to Ship to Patients]]> Wed, 5 Dec 2001 15:43:00 +0100 http://cws.huginonline.com/A/131801/PR/200112/1212074_5.html Actelion Pharmaceuticals Ltd <![CDATA[Canadian Health Authority approves Actelion's Tracleer(TM) ]]> Mon, 3 Dec 2001 15:40:00 +0100 http://cws.huginonline.com/A/131801/PR/200112/1212069_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion Announces U.S. Commercial Availability of Tracleer(TM) (bosentan) tablets - First Oral Treatment for Pulmonary Arterial Hypertension Ready to Ship to Patients]]> Mon, 3 Dec 2001 15:32:00 +0100 http://cws.huginonline.com/A/131801/PR/200112/1212058_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion's Tracleer(TM) (bosentan) tablets approved by the US Food and Drug Administration - First oral treatment of Pulmonary Arterial Hypertension]]> Tue, 20 Nov 2001 15:28:00 +0100 http://cws.huginonline.com/A/131801/PR/200111/1212055_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion reports financial figures for Q3 2001]]> Tue, 13 Nov 2001 15:24:00 +0100 http://cws.huginonline.com/A/131801/PR/200111/1212051_5.html Actelion Pharmaceuticals Ltd <![CDATA[Tracleer(TM) receives Approvable Letter from the FDA]]> Mon, 17 Sep 2001 15:21:00 +0200 http://cws.huginonline.com/A/131801/PR/200109/1212048_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion to initiate dose-optimization study of Veletri(TM) in the treatment of Acute Heart Failure]]> Tue, 4 Sep 2001 14:56:00 +0200 http://cws.huginonline.com/A/131801/PR/200109/1212013_5.html Actelion Pharmaceuticals Ltd <![CDATA[FDA Advisory Committee Votes Unanimously to Recommend Approval of Tracleer(TM) for Treatment of Pulmonary Arterial Hypertension]]> Fri, 10 Aug 2001 14:53:00 +0200 http://cws.huginonline.com/A/131801/PR/200108/1212007_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion reports financial figures for Q2 2001]]> Tue, 7 Aug 2001 14:50:00 +0200 http://cws.huginonline.com/A/131801/PR/200108/1212002_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion and R.W. Johnson Pharmaceutical Research Institute renew research collaboration ]]> Mon, 25 Jun 2001 14:47:00 +0200 http://cws.huginonline.com/A/131801/PR/200106/1211992_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion invited to FDA Advisory Board Meeting]]> Wed, 20 Jun 2001 14:44:00 +0200 http://cws.huginonline.com/A/131801/PR/200106/1211989_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion reports financial figures for Q1 2001]]> Tue, 8 May 2001 14:42:00 +0200 http://cws.huginonline.com/A/131801/PR/200105/1211983_5.html Actelion Pharmaceuticals Ltd <![CDATA[PHASE III CLINICAL TRIAL OF VELETRI(TM) FOR THE TREATMENT OF ACUTE HEART FAILURE SYMPTOMS DOES NOT MEET PRIMARY EFFICACY OBJECTIVE]]> Fri, 20 Apr 2001 14:26:00 +0200 http://cws.huginonline.com/A/131801/PR/200104/1211970_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion shareholders approve four-to-one stock split]]> Mon, 9 Apr 2001 13:01:00 +0200 http://cws.huginonline.com/A/131801/PR/200104/1211901_5.html Actelion Pharmaceuticals Ltd <![CDATA[First endothelin receptor antagonist shows positive preliminary results for acute heart failure]]> Tue, 20 Mar 2001 11:56:00 +0100 http://cws.huginonline.com/A/131801/PR/200103/1211842_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion fully prepared for first market introduction]]> Mon, 12 Mar 2001 11:51:00 +0100 http://cws.huginonline.com/A/131801/PR/200103/1211832_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion files for EU authorization for bosentan (TracleerTM) in pulmonary arterial hypertension]]> Thu, 1 Mar 2001 11:48:00 +0100 http://cws.huginonline.com/A/131801/PR/200103/1211823_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion obtains Orphan Medicinal Product designation for bosentan (TracleerTM) in pulmonary arterial hypertension from European Commission]]> Wed, 21 Feb 2001 11:43:00 +0100 http://cws.huginonline.com/A/131801/PR/200102/1211815_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion increases revenues eleven-fold in its third year of activities]]> Wed, 14 Feb 2001 09:25:00 +0100 http://cws.huginonline.com/A/131801/PR/200102/1212378_5.html Actelion Pharmaceuticals Ltd <![CDATA[Phase III trial of intravenous endothelin receptor antagonist TEZOSENTAN for Acute Heart Failure shows positive hemodynamic results]]> Tue, 13 Feb 2001 11:39:00 +0100 http://cws.huginonline.com/A/131801/PR/200102/1211812_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion strengthens its management team]]> Tue, 23 Jan 2001 11:35:00 +0100 http://cws.huginonline.com/A/131801/PR/200101/1211803_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion and Genentech sign licensing agreement for TracleerTM (bosentan) in the U.S.]]> Wed, 13 Dec 2000 09:20:00 +0100 http://cws.huginonline.com/A/131801/PR/200012/1212374_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion completes NDA submission to the FDA for TRACLEERTM (bosentan) in pulmonary arterial hypertension]]> Wed, 22 Nov 2000 09:17:00 +0100 http://cws.huginonline.com/A/131801/PR/200011/1212367_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion reports third quarter results on track]]> Thu, 9 Nov 2000 09:13:00 +0100 http://cws.huginonline.com/A/131801/PR/200011/1212355_5.html Actelion Pharmaceuticals Ltd <![CDATA[FDA grants Actelion Orphan Drug Designation for bosentan in pulmonary arterial hypertension]]> Mon, 16 Oct 2000 09:04:00 +0200 http://cws.huginonline.com/A/131801/PR/200010/1212350_5.html Actelion Pharmaceuticals Ltd <![CDATA[Secondary Offering of Actelion Ltd.]]> Mon, 2 Oct 2000 08:59:00 +0200 http://cws.huginonline.com/A/131801/PR/200010/1212342_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion submits first part of NDA for bosentan in pulmonary hypertension to the US FDA]]> Tue, 26 Sep 2000 08:56:00 +0200 http://cws.huginonline.com/A/131801/PR/200009/1212338_5.html Actelion Pharmaceuticals Ltd <![CDATA[Clinical trials of Actelion's two flagship drugs are on track and obtain green light from safety committees]]> Thu, 31 Aug 2000 08:52:00 +0200 http://cws.huginonline.com/A/131801/PR/200008/1212334_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion shows accelerated growth for second quarter]]> Tue, 8 Aug 2000 08:48:00 +0200 http://cws.huginonline.com/A/131801/PR/200008/1212328_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion posts positive result for First Quarter 2000]]> Wed, 10 May 2000 08:37:00 +0200 http://cws.huginonline.com/A/131801/PR/200005/1212318_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion announces positive results]]> Tue, 2 May 2000 08:43:00 +0200 http://cws.huginonline.com/A/131801/PR/200005/1212323_5.html Actelion Pharmaceuticals Ltd <![CDATA[Actelion is going public - Placement of up to 1 million shares - SWX New Market Listing]]> Thu, 23 Mar 2000 08:40:00 +0100 http://cws.huginonline.com/A/131801/PR/200003/1212321_5.html Actelion Pharmaceuticals Ltd